UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014487
Receipt number R000016853
Scientific Title Examination about the usefulness of the acetaminophen for intravenous injections after the operation of laparoscopic groin hernia restoration
Date of disclosure of the study information 2014/07/07
Last modified on 2016/12/28 08:27:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination about the usefulness of the acetaminophen for intravenous injections after the operation of laparoscopic groin hernia restoration

Acronym

Examination about the usefulness of the acetaminophen for intravenous injections after the operation of laparoscopic groin hernia restoration

Scientific Title

Examination about the usefulness of the acetaminophen for intravenous injections after the operation of laparoscopic groin hernia restoration

Scientific Title:Acronym

Examination about the usefulness of the acetaminophen for intravenous injections after the operation of laparoscopic groin hernia restoration

Region

Japan


Condition

Condition

groin hernia

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

A pain occurs after the laparoscopic groin hernia restoration in a short term. NSAIDs or fentanyl continuous intravenous infusion is used to hang around for the sharp pain by facilities and an anesthesiologist, a surgeon.
This time, we attempt to study the usage of the acetaminophen for intravenous injections whether it was useful for painkilling after the laparoscopic groin hernia restoration and it could reduce perioperative opioid consumption.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

Dosage of additional pain-killer

Key secondary outcomes

Pain level, time of pain-killer use, the number of the harmful phenomenon (shivering, nausea, vomiting)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Control group:Fentanyl sustained intravenous administration (0.3 micro gram/kg/h), given since 30 minutes before operation end.

Interventions/Control_2

Study group:Use the Intravenous acetaminophen since 30 minutes before operation end, and 3 times per 6 hour.Dosage is 15 mg/kg for the patient less than 50 kg in weight and 1000 mg for the patient more than 50 kg in weight.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

All patients who receive a target operation

Key exclusion criteria

A patient who always use a pain-killer, has a liver function disorder(AST or ALT>100), is obesity(BMI >=30), cannot understand the protocol.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Michihisa Kato

Organization

Tokushima Red Cross Hospital

Division name

Anesthesiology

Zip code


Address

Komatsushima Irinokuchi 103

TEL

0885-32-2555

Email

mmkato@tokushima-med.jrc.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masanori Go

Organization

Tokushima Red Cross Hospital

Division name

Anesthesiology

Zip code


Address

Komatsushima Irinokuchi 103

TEL

0885-32-2555

Homepage URL


Email

mgo@tokushima-med.jrc.or.jp


Sponsor or person

Institute

Tokushima Red Cross Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 07 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 07 Month 07 Day

Date of IRB


Anticipated trial start date

2014 Year 07 Month 07 Day

Last follow-up date

2015 Year 08 Month 31 Day

Date of closure to data entry

2016 Year 11 Month 15 Day

Date trial data considered complete

2016 Year 11 Month 15 Day

Date analysis concluded

2016 Year 11 Month 15 Day


Other

Other related information



Management information

Registered date

2014 Year 07 Month 06 Day

Last modified on

2016 Year 12 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016853


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name